187 related articles for article (PubMed ID: 22620485)
1. The FKBP-rapamycin binding domain of human TOR undergoes strong conformational changes in the presence of membrane mimetics with and without the regulator phosphatidic acid.
Rodriguez Camargo DC; Link NM; Dames SA
Biochemistry; 2012 Jun; 51(24):4909-21. PubMed ID: 22620485
[TBL] [Abstract][Full Text] [Related]
2. Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR.
Veverka V; Crabbe T; Bird I; Lennie G; Muskett FW; Taylor RJ; Carr MD
Oncogene; 2008 Jan; 27(5):585-95. PubMed ID: 17684489
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the FKBP.rapamycin.FRB ternary complex.
Banaszynski LA; Liu CW; Wandless TJ
J Am Chem Soc; 2005 Apr; 127(13):4715-21. PubMed ID: 15796538
[TBL] [Abstract][Full Text] [Related]
4. Saccharomyces cerevisiae FKBP12 binds Arabidopsis thaliana TOR and its expression in plants leads to rapamycin susceptibility.
Sormani R; Yao L; Menand B; Ennar N; Lecampion C; Meyer C; Robaglia C
BMC Plant Biol; 2007 Jun; 7():26. PubMed ID: 17543119
[TBL] [Abstract][Full Text] [Related]
5. Distinctive expression and functional regulation of the maize (Zea mays L.) TOR kinase ortholog.
Agredano-Moreno LT; Reyes de la Cruz H; Martínez-Castilla LP; Sánchez de Jiménez E
Mol Biosyst; 2007 Nov; 3(11):794-802. PubMed ID: 17940662
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function.
Oshiro N; Yoshino K; Hidayat S; Tokunaga C; Hara K; Eguchi S; Avruch J; Yonezawa K
Genes Cells; 2004 Apr; 9(4):359-66. PubMed ID: 15066126
[TBL] [Abstract][Full Text] [Related]
7. The FRB domain of mTOR: NMR solution structure and inhibitor design.
Leone M; Crowell KJ; Chen J; Jung D; Chiang GG; Sareth S; Abraham RT; Pellecchia M
Biochemistry; 2006 Aug; 45(34):10294-302. PubMed ID: 16922504
[TBL] [Abstract][Full Text] [Related]
8. A fast and simple method to prepare the FKBP-rapamycin binding domain of human target of rapamycin for NMR binding assays.
Dames SA
Protein Expr Purif; 2008 May; 59(1):31-7. PubMed ID: 18313330
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of target of rapamycin signaling by rapamycin in the unicellular green alga Chlamydomonas reinhardtii.
Crespo JL; Díaz-Troya S; Florencio FJ
Plant Physiol; 2005 Dec; 139(4):1736-49. PubMed ID: 16299168
[TBL] [Abstract][Full Text] [Related]
10. Multi-timescale dynamics study of FKBP12 along the rapamycin-mTOR binding coordinate.
Sapienza PJ; Mauldin RV; Lee AL
J Mol Biol; 2011 Jan; 405(2):378-94. PubMed ID: 21073880
[TBL] [Abstract][Full Text] [Related]
11. Arabidopsis TARGET OF RAPAMYCIN interacts with RAPTOR, which regulates the activity of S6 kinase in response to osmotic stress signals.
Mahfouz MM; Kim S; Delauney AJ; Verma DP
Plant Cell; 2006 Feb; 18(2):477-90. PubMed ID: 16377759
[TBL] [Abstract][Full Text] [Related]
12. An evaluation tool for FKBP12-dependent and -independent mTOR inhibitors using a combination of FKBP-mTOR fusion protein, DSC and NMR.
Sekiguchi M; Kobashigawa Y; Kawasaki M; Yokochi M; Kiso T; Suzumura K; Mori K; Teramura T; Inagaki F
Protein Eng Des Sel; 2011 Nov; 24(11):811-7. PubMed ID: 21900305
[TBL] [Abstract][Full Text] [Related]
13. The FKBP12-rapamycin-binding domain is required for FKBP12-rapamycin-associated protein kinase activity and G1 progression.
Vilella-Bach M; Nuzzi P; Fang Y; Chen J
J Biol Chem; 1999 Feb; 274(7):4266-72. PubMed ID: 9933627
[TBL] [Abstract][Full Text] [Related]
14. FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells.
Fruman DA; Wood MA; Gjertson CK; Katz HR; Burakoff SJ; Bierer BE
Eur J Immunol; 1995 Feb; 25(2):563-71. PubMed ID: 7533090
[TBL] [Abstract][Full Text] [Related]
15. mTOR kinase structure, mechanism and regulation.
Yang H; Rudge DG; Koos JD; Vaidialingam B; Yang HJ; Pavletich NP
Nature; 2013 May; 497(7448):217-23. PubMed ID: 23636326
[TBL] [Abstract][Full Text] [Related]
16. The role of glycerol-water mixtures in the stability of FKBP12-rapalog-FRB complexes.
Lopez JJD; Gaza JT; Nellas RB
J Mol Graph Model; 2023 Nov; 124():108556. PubMed ID: 37423019
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the immersion properties of the peripheral membrane anchor of the FATC domain of the kinase "target of rapamycin" by NMR, oriented CD spectroscopy, and MD simulations.
Sommer LA; Janke JJ; Bennett WF; Bürck J; Ulrich AS; Tieleman DP; Dames SA
J Phys Chem B; 2014 May; 118(18):4817-31. PubMed ID: 24725177
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of purified recombinant mTOR FRB-kinase domain using fluorescence-based assays.
Reichling LJ; Lebakken CS; Riddle SM; Vedvik KL; Robers MB; Kopp LM; Bruinsma R; Vogel KW
J Biomol Screen; 2008 Mar; 13(3):238-44. PubMed ID: 18354135
[TBL] [Abstract][Full Text] [Related]
19. Target of rapamycin FATC domain as a general membrane anchor: The FKBP-12 like domain of FKBP38 as a case study.
De Cicco M; Milroy LG; Dames SA
Protein Sci; 2018 Feb; 27(2):546-560. PubMed ID: 29024217
[TBL] [Abstract][Full Text] [Related]
20. Regulation of mTOR by phosphatidic acid.
Frias MA; Hatipoglu A; Foster DA
Trends Endocrinol Metab; 2023 Mar; 34(3):170-180. PubMed ID: 36732094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
